Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Martínez, C.
Right arrow Articles by Agúndez, J. A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martínez, C.
Right arrow Articles by Agúndez, J. A. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 8, 1323-1326, August 2001
© 2001 Oxford University Press

SHORT COMMUNICATION

Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk

Carmen Martínez, Elena García-Martín1,, José M. Ladero2,, Javier Sastre3,, Francisco Garcia-Gamito4,, Manuel Diaz-Rubio2, and José A. G. Agúndez5,

Department of Pharmacology, Medical School and
1 Department of Biochemistry, School of Biological Sciences, University of Extremadura, Avda. de Elvas s/n, E-06071, Badajoz,
2 Department of Gastroenterology and
3 Department of Medical Oncology, San Carlos University Hospital, Prof. Martin Lagos s/n, E-28040, Madrid and
4 Department of Surgery, Hospital Insalud, Pol. Nueva Ciudad s/n, E-06800, Mérida, Spain

CYP2C9 enzyme activity is involved in the metabolism of substances related to colorectal cancer, and it is functionally linked to a genetic polymorphism. Two allelic variants of the CYP2C9 gene, namely CYP2C9*2 and CYP2C9*3, differ from wild-type CYP2C9*1 by single amino acid substitutions. These mutated alleles encode enzymes with altered properties that are associated with impaired metabolism. The present study evaluates the impact of CYP2C9 genotypes leading to high enzyme activity on colorectal cancer risk. For this, the frequency of allelic variants of the CYP2C9 gene was analysed in genomic DNA from 129 patients with colorectal cancer and in 150 healthy controls. Patients with colorectal cancer showed a statistically significant increase in the frequency of genotypes homozygous for the active CYP2C9*1 gene, as compared with healthy individuals. Such a high frequency is more significant among patients with cancer in proximal segments of the colon (P < 0.025; odds ratio 2.36 95% CI 1.18–4.72), and decreases in more distal tumour locations. We conclude that CYP2C9 polymorphism can be considered as a secondary risk factor for colorectal cancer in the studied population: those individuals with genotypes leading to high enzyme activity were at increased risk. The association of the CYP2C9 polymorphism to colorectal cancer risk could be related to CYP2C9-mediated metabolic activation of polycyclic aromatic hydrocarbons and heterocyclic aromatic amines. In addition, the key role of CYP2C9 in the metabolic inactivation of non-steroidal anti- inflammatory drugs could diminish the protective effect of these drugs against colorectal cancer.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. Kury, B. Buecher, S. Robiou-du-Pont, C. Scoul, V. Sebille, H. Colman, C. Le Houerou, T. Le Neel, J. Bourdon, R. Faroux, et al.
Combinations of Cytochrome P450 Gene Polymorphisms Enhancing the Risk for Sporadic Colorectal Cancer Related to Red Meat Consumption
Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1460 - 1467.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. G.J. van Breda, E. van Agen, L. G.J.B. Engels, E. J.C. Moonen, J. C.S. Kleinjans, and J. H.M. van Delft
Altered vegetable intake affects pivotal carcinogenesis pathways in colon mucosa from adenoma patients and controls
Carcinogenesis, November 1, 2004; 25(11): 2207 - 2216.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. M. de Jong, I. M. Nolte, G. J. te Meerman, W. T. A. van der Graaf, E. G. E. de Vries, R. H. Sijmons, R. M. W. Hofstra, and J. H. Kleibeuker
Low-penetrance Genes and Their Involvement in Colorectal Cancer Susceptibility
Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1332 - 1352.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
K. Hemminki and A. Forsti
Proper controls for SNP studies?
Carcinogenesis, August 1, 2002; 23(8): 1405 - 1406.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
U. Yasar, E. Eliasson, and M.-L. Dahl
Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk
Carcinogenesis, April 1, 2002; 23(4): 665 - 665.
[Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. Martinez, E. Garcia-Martin, J. M. Ladero, J. Sastre, F. Garcia-Gamito, M. Diaz-Rubio, and J. A.G. Agundez
Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk
Carcinogenesis, April 1, 2002; 23(4): 667 - 668.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.